News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
IMYN
[img]http://stockcharts.com/c-sc/sc?s=IMYN&p=D&b=5&g=0&i=t71445902743&r=2490[img]
Seeking FDA Approval
Perfect Timing as Stock is at all time lows too. Small Float! This will run back to a $1.50 in no time. Get it now. Good Luck to all.
“Regulatory approval processes for IMYN have been initiated in several countries. Additionally, in both the US and Europe preparations for clinical trials are underway. Research indicates that it has the potential to affect neurological disorders such as Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Reflex Sympathetic Dystrophy Syndrome (RSD or RSDS), autoimmune disorders such as Multiple Sclerosis (MS), and a number of clinical conditions including complications from Diabetic Mellitus such as Diabetic Neuropathy (DN) and diabetic ulcers (DU).”
“We have a drug that is fully developed, which our Scientific Advisory Board believes has demonstrated safety and efficacy for indications for which we hope the treatment will be approved. We are in the marketplace raising awareness and are cognizant of the need to set up a viable distribution system. We are at the cutting-edge of where drug development and therapies are today. The two Orphan Diseases for which Argyll Biotechnologies plans to seek FDA approval in the US are Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Reflex Sympathetic Dystrophy (RSD or RSDS). However, the overall target market is potentially broader. It could include indications such as Multiple Sclerosis (MS), from which an estimated 2.5 million people suffer worldwide. There is also the potential to be used in treating complications from Diabetic Mellitus such as Diabetic Neuropathy (DN) and diabetic ulcers (DU). Worldwide, approximately 246 million people have Diabetes Mellitus, of those, 1 in 6 will develop a foot ulcers and an estimated 50% have a Diabetic Neuropathy (DN). Therefore, there is certainly a large potential market. From a business standpoint as well as a humanitarian standpoint, we feel there is great potential.”
- Stephen D. Ferrone, CEO
http://finance.yahoo.com/q?s=IMYN.PK&ql=1
PSPW
BREAKOUT ALERT: PIHN
ABPH huge volume breakout
NUBL on watch
MCET looking here for new hods
NEGS - Daily Candlesticks
ECOF - Daily Candlesticks
STTN -that one is still incubating / bid getting stronger => expect a move
that is a REALLY GOOD ONE !
ATIG - Daily Candlesticks
buy the dips here -> ZLUS - Daily Candlesticks
TBJK
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=7204306
GENERAL
The Board approved a resolution to effectuate a 540.61745923707:1 reverse stock split. Under this reverse stock split each 540.61745923707 shares of our Common Stock will be automatically converted into 1 share of Common Stock. To avoid the issuance of fractional shares of Common Stock, the Company will issue an additional share to all holders of fractional shares. The effective date of the reverse stock split will be November 16, 2010.
PLEASE NOTE THAT THE REVERSE STOCK SPLIT WILL NOT CHANGE YOUR PROPORTIONATE EQUITY INTERESTS IN THE COMPANY, EXCEPT AS MAY RESULT FROM THE ISSUANCE OR CANCELLATION OF SHARES PURSUANT TO THE FRACTIONAL SHARES.
I like discovering unknown companies with "lotto" potential. I often take a "wade into the water" approach rather than a leap off the high board and it has worked well for me.
Another one - TBJK @.0039 on vol. of 269,950 52 wk range .003-30
Timberjack Sporting Supplies, Inc. Completes Merger With Chine Victory Profit Limited and $5.34 Million Private Placement
LINYI CITY, China, Oct. 1, 2010 (GLOBE NEWSWIRE) -- Timberjack Sporting Supplies, Inc. (the "Company") (OTCBB:TBJK - News) completed an acquisition of Chine Victory Profit Limited ("Chine Victory"), a Company engaged in the production of radiata pine plywood and eucalyptus plywood products, by means of a share exchange, effective September 30, 2010 (the "Share Exchange"). As a result of the Share Exchange, Chine Victory became a wholly-owned subsidiary of TBJK.
Chine Victory, operating through its affiliated entities: Simply Good Limited, Moody International Limited, Linyi Guangsha Wood Industry Co. Ltd., and together with Linyi Chan Tseng Wood Co., Ltd., is engaged in the production of industrial quality radiata pine plywood and eucalyptus plywood products. The Company is also a large producer of veneer, which can be described as thin layers of superior wood glued to a base of inferior wood. The products are produced from pine and eucalyptus woods.
On September 30, 2010, the Company completed a US$5,344,975 private placement of its securities to accredited investors at $4.00 per Unit, with each "Unit" consisting of one share of Series A Convertible Preferred Stock, and a five year warrant exercisable for 0.5 shares of common stock with an exercise price of $4.80 per share. Newbridge Securities Corporation acted as the lead placement agent and adviser to Chine Victory. The private placement was completed in connection with the Share Exchange. The Company plans to use the net proceeds for the expansion of its warehousing and logistics facilities, processing equipment, and working capital.
In connection with the Share Exchange and private placement, the majority shareholders and directors of TBJK have approved a reverse stock split of approximately 540 to 1.
On September 30, 2010, the Board appointed Parker Randall as the Company's new independent registered public accounting firm. The decision to engage Parker Randall was approved by the Company's Board of Directors on September 30, 2010.
http://finance.yahoo.com/q?s=TBJK.PK
PUDA weekly trigger
PIHN 0004/5 > EXPLOSION SOON, IMO....
Profitable 10Q coming: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=53707455
Acquisition of a HUGE company: http://finance.yahoo.com/news/Polaris-International-prnews-1583857643.html?x=0&.v=1
PIHN nice NEWS and annotated Chart
by Sitti
MYFT on watch -> annotated Chart by mtcinc0
IDCN Chart
AMSZ -> Chart
AGEL Lottoplay...rumors about news and maybe a merger
HMIT chart next target
MMTC on watch! -> Chart
CTIX news
http://ih.advfn.com/p.php?pid=nmona&article=43211917&symbol=CTIX
New Autism Drug Research by Cellceutix on Compound KM-391 Results in Significant Behavioral Changes; Chief Scientific Officer Se
HMIT...ENTI...ECLR...HFBG...Charts
a pump will start this week
where is the bottom?
volumen alert
EC removing and contract expected this week
|
Followers
|
5
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
418
|
|
Created
|
10/18/09
|
Type
|
Free
|
| Moderators | |||
Only Pennystocks
newsletter alerts click the picture above
buy in now 15.4.
PTSHD
our 10 +++ bagger
Disclaimer:
I have never ever been paid or compensated by anyone for any stock I trade or discuss.
I am not a licensed broker or a professional by any means, so take what I say as entertainment value at best.
Make your own DD.
"Earn Mo money"
*****************************************************************************************************************************************************************
HMIT: 0.0004
Date: 04/09/10
Target: 0.01+
Note: MA300 - MA500 just for fun
